The Leona M. and Harry B. Helmsley Charitable Trust awarded the funds to expand its support of the Stenosis Therapy and Anti-Fibrotic Research (STAR) consortium for the development of biomarker tools for intestinal fibrosis in patients with Crohn's disease.